mRNA COVID Vaccines Boost Cancer Immunotherapy Effectiveness
Originally Published 2 months ago — by bioengineer.org
Researchers at MD Anderson Cancer Center presented at ESMO 2025 that mRNA COVID-19 vaccines significantly boost the efficacy of cancer immunotherapy, especially in tumors with low baseline immune activity, by enhancing immune responses and increasing tumor susceptibility to checkpoint blockade, potentially transforming cancer treatment protocols.